WT1: a weak spot in KRAS-induced transformation.
暂无分享,去创建一个
[1] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[2] J. Downward. Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells , 2004, Oncogene.
[3] R. DePinho,et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.
[4] M. Rivera,et al. Wilms' tumour: connecting tumorigenesis and organ development in the kidney , 2005, Nature Reviews Cancer.
[5] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[6] S. Elledge,et al. Dissecting cancer pathways and vulnerabilities with RNAi. , 2005, Cold Spring Harbor symposia on quantitative biology.
[7] W. Kaelin. The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.
[8] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[9] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[10] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[11] Michael Karin,et al. Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.
[12] René Bernards,et al. shRNA libraries and their use in cancer genetics , 2006, Nature Methods.
[13] M. Minden,et al. A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.
[14] Robert A. Weinberg,et al. Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.
[15] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.
[16] Michael J. Emanuele,et al. A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene , 2009, Cell.
[17] D. Tuveson,et al. RAS in cellular transformation and senescence. , 2009, European journal of cancer.
[18] Sridhar Ramaswamy,et al. Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells , 2009, Cell.
[19] Anjana Rao,et al. RNAi screening: tips and techniques , 2009, Nature Immunology.
[20] W. Hahn,et al. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. , 2010, The Journal of clinical investigation.
[21] N. Younga,et al. Tissue-specific p 19 [ superscript Arf ] regulation dictates the response to oncogenic Kras , 2010 .
[22] T. Jacks,et al. Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras , 2010, Proceedings of the National Academy of Sciences.